Brief: Innate Pharma Shares Updated Results From The Sanofi Developed Blood Cancer Phase 1/2 Sar443579/Iph6101 Trial
17/06/2024 06:02
June 17 (Reuters) - Innate Pharma SA IPH.PA :
* INNATE PHARMA SHARES UPDATED RESULTS FROM THE SANOFI
DEVELOPED
BLOOD CANCER PHASE 1/2 SAR443579/IPH6101 TRIAL
Source text for Eikon: ID:nBwtnrpca
Further company coverage: [IPH.PA SASY.PA]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innate Pharma SA
See all newsFrance's Innate Pharma posts lower 2025 revenue as key contracts decline
Brief: Innate Pharma FY Operating Expenses EUR -63.013 Million
Brief: Innate Pharma Sa Says Sanofi to invest up to 15 million Euros In Innate Pharma
Brief: Innate Pharma Says Jonathan Dickinson To Be Appointed CEO And Board Member
French and Benelux stocks-Factors to watch